文献速递肝病

肝失代偿的无创评估

Noninvasive assessment of hepatic decompensation.
PubMed 文献 · Hepatology · 2023-10-06

本综述阐述无创检测(NITs)在肝失代偿管理中的应用与陷阱,涵盖从初级保健风险分层到门诊治疗决策及慢加急性肝衰竭住院管理。Baveno VI和VII共识会议推动了代偿期和失代偿期进展性慢性肝病诊疗路径的改进,包括联合血小板计数和瞬时弹性成像诊断临床显著门静脉高压。循环NITs在评估腹水、静脉曲张出血、肝性脑病、急性肾损伤和感染干预反应中的作用将日益重要。

要点

  • NITs基于经验证的截断值和标准化解读,可作为临床判断的有价值补充。
  • Baveno VI和VII共识推荐联合血小板计数和瞬时弹性成像诊断临床显著门静脉高压。
  • NITs广泛可及存在使用不当风险,可能导致资源浪费和决策失误。

核心结论

  • NITs不仅提供早期诊断机会,还可用于准确预后判断、靶向治疗决策和疾病监测。
  • NITs可基于经验证的截断值和标准化解读辅助疾病管理和决策,作为临床判断的有价值补充。
  • 循环NITs在评估针对腹水、静脉曲张出血、肝性脑病、急性肾损伤和感染的干预反应中将发挥日益重要的作用。
  • 由于NITs广泛可及,存在使用不当的风险,可能导致资源浪费和决策失误。

研究设计与样本

  • 本文为综述,描述NITs在肝失代偿中的应用与陷阱,涵盖从初级保健风险分层到门诊治疗决策及慢加急性肝衰竭住院管理。

主要发现

  • Baveno VI和VII共识会议推动了代偿期和失代偿期进展性慢性肝病诊疗路径的切实改进。
  • 上述改进包括联合血小板计数和瞬时弹性成像诊断临床显著门静脉高压。
  • 循环NITs在评估针对腹水、静脉曲张出血、肝性脑病、急性肾损伤和感染的干预反应中将发挥日益重要的作用。

关键数值与推荐

  • Baveno VI和VII共识推荐联合血小板计数和瞬时弹性成像诊断临床显著门静脉高压。
  • NITs的使用应基于经验证的截断值和标准化解读。

临床怎么用

  • NITs可用于初级保健中的风险分层、门诊治疗决策以及慢加急性肝衰竭患者的住院管理。
  • NITs应作为临床判断的有价值补充,基于经验证的截断值和标准化解读辅助疾病管理和决策。

局限性

  • 由于NITs广泛可及,存在使用不当的风险,可能导致资源浪费和决策失误。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Noninvasive tests (NITs) are used in all aspects of liver disease management. Their most prominent break-through since the millennium has been in advancing early detection of liver fibrosis, but their use is not limited to this. In contrast to the symptom-driven assessment of decompensation in patients with cirrhosis, NITs provide not only opportunities for earlier diagnoses but also accurate prognostication, targeted treatment decisions, and a means of monitoring disease. NITs can inform disease management and decision-making based on validated cutoffs and standardized interpretations as a valuable supplement to clinical acumen. The Baveno VI and VII consensus meetings resulted in tangible improvements to pathways of care for patients with compensated and decompensated advanced chronic liver disease, including the combination of platelet count and transient elastography to diagnose clinically significant portal hypertension. Furthermore, circulating NITs will play increasingly important roles in assessing the response to interventions against ascites, variceal bleeding, HE, acute kidney injury, and infections. However, due to NITs' wide availability, there is a risk of inaccurate use, leading to a waste of resources and flawed decisions. In this review, we describe the uses and pitfalls of NITs for hepatic decompensation, from risk stratification in primary care to treatment decisions in outpatient clinics, as well as for the in-hospital management of patients with acute-on-chronic liver failure. We summarize which NITs to use when, for what indications, and how to maximize the potential of NITs for improved patient management.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Thiele M, Johansen S, Israelsen M, et al. Noninvasive assessment of hepatic decompensation. Hepatology. 2023. PMID: 37801593. doi:10.1097/HEP.0000000000000618

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。